Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Dec;73(12):4645-8.
doi: 10.1073/pnas.73.12.4645.

Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants

Human alpha-fetoprotein as a modulator of human lymphocyte transformation: correlation of biological potency with electrophoretic variants

E P Lester et al. Proc Natl Acad Sci U S A. 1976 Dec.

Abstract

Human alpha-fetoprotein (HAFP) isolated by immunoadsorbent column was shown to suppress the mitogenic response of human lymphocytes to phytomitogens, antihuman thymocyte antiserum, and the mixed lymphocyte culture. HAFP isolated from the sera and ascitic fluid of five hepatoma patients, and from fetal liver, varied in biological potency over three orders of magnitude. Extended agarose gel electrophoresis and crossed immunoelectrophoresis demonstrated three molecular species of HAFP. Quantitation of the three species revealed a correlation between the relative amount of the most negatively charged species and biological potency. Treatment of HAFP with neuraminidase to remove completely sialic acid residues did not alter the biological potency, but converted the three species to two species having slower electrophoretic mobilities. We conclude that differences in sialic acid content are only partly responsible for the microheterogeneity demonstrated by HAFP, and that variability in another charged moiety is also present. Variation in the relative proportions of the different molecular species of HAFP may be important in the regulation of its immunosuppressive properties.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1959 Aug;234(8):1971-5 - PubMed
    1. J Biol Chem. 1972 Jun 25;247(12):3792-8 - PubMed
    1. J Biol Chem. 1974 Jul 10;249(13):4202-6 - PubMed
    1. J Biol Chem. 1974 Aug 25;249(16):5275-84 - PubMed
    1. Clin Exp Immunol. 1972 May;11(1):109-24 - PubMed

Publication types

MeSH terms

LinkOut - more resources